Results 1 to 10 of about 205,272 (146)

Secondary Immunodeficiency [PDF]

Allergy, Asthma & Clinical Immunology
The field of medicine is constantly changing and, as healthcare providers, we are fortunate to be practicing in a time when patients are living longer and novel therapeutic options continue to evolve.
Persia Pourshahnazari, Stephen D. Betschel, Vy. H. D. Kim, Susan Waserman, Rongbo Zhu, Harold Kim   +5 more
doaj   +4 more sources

Patient-reported outcomes with subcutaneous immunoglobulin in secondary immunodeficiency [PDF]

Frontiers in Immunology
Subcutaneous (SCIG) and intravenous immunoglobulin (IVIG) replacement are both used to prevent infections in patients with secondary immunodeficiency (SID).
Juthaporn Cowan, Juthaporn Cowan, Juthaporn Cowan, Il-Kang Na, Il-Kang Na, Il-Kang Na, Il-Kang Na, André Gladiator, Marta Kamieniak, S. Shahzad Mustafa, S. Shahzad Mustafa   +10 more
doaj   +4 more sources

Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience [PDF]

Frontiers in Immunology, 2022
BackgroundIndividuals with primary and secondary immunodeficiency (PID/SID) were shown to be at risk of poor outcomes during the early stages of the SARS-CoV-2 pandemic.
Adrian M. Shields, Adrian M. Shields, Susan Tadros, Adam Al-Hakim, Jeremy M. Nell, Me Me Nay Lin, Michele Chan, Sarah Goddard, John Dempster, Magdalena Dziadzio, Smita Y. Patel, Smita Y. Patel, Shuayb Elkalifa, Aarnoud Huissoon, Christopher J. A. Duncan, Archana Herwadkar, Sujoy Khan, Claire Bethune, Suzanne Elcombe, James Thaventhiran, Paul Klenerman, David M. Lowe, David M. Lowe, Sinisa Savic, Siobhan O. Burns, Siobhan O. Burns, Alex G. Richter, Alex G. Richter   +27 more
doaj   +4 more sources

Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review [PDF]

Frontiers in Oncology, 2023
IntroductionPatients with hematological malignancies (HMs), like chronic lymphocytic leukemia (CLL), multiple myeloma (MM), and non-Hodgkin lymphoma (NHL), have a high risk of secondary immunodeficiency (SID), SID-related infections, and mortality. Here,
Stephen Jolles, Sergio Giralt, Tessa Kerre, Hillard M. Lazarus, S. Shahzad Mustafa, S. Shahzad Mustafa, Roberto Ria, Donald C. Vinh   +7 more
doaj   +4 more sources

Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency [PDF]

Frontiers in Microbiology, 2022
Since the end of 2019, the world has been challenged by the coronavirus disease 2019 (COVID-19) pandemic. With COVID-19 cases rising globally, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, resulting in the emergence of
Nathan M. Markarian, Nathan M. Markarian, Nathan M. Markarian, Gaël Galli, Gaël Galli, Gaël Galli, Gaël Galli, Dhanesh Patel, Dhanesh Patel, Mark Hemmings, Priya Nagpal, Albert M. Berghuis, Levon Abrahamyan, Silvia M. Vidal, Silvia M. Vidal   +14 more
doaj   +4 more sources

Rethinking secondary immunodeficiency: a cross-domain pathway framework for risk stratification [PDF]

Frontiers in Immunology
BackgroundSecondary immunodeficiency (SID) arises from malignancy, immunomodulatory therapies, organ dysfunction, chronic infection, malnutrition, and aging.
Iqra Mumtaz
doaj   +2 more sources

Economic impact of immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer: a single center observational study [PDF]

Frontiers in Immunology
This is the first report of the health economic benefits derived from preventing infections through Immunoglobulin Replacement Therapy (IgRT) in patients with secondary immunodeficiency due to hematological malignancies.
Luciana del Campo Guerola, Luciana del Campo Guerola, Ana Andrea García Sacristán, Antonio Portolés, Maricruz Jasso, Teresa Guerra-Galán, Teresa Guerra-Galán, Eduardo de la Fuente-Munoz, Eduardo de la Fuente-Munoz, María Palacios-Ortega, María Palacios-Ortega, Miguel Fernández-Arquero, Miguel Fernández-Arquero, Cristina Cuesta-Mínguez, Aránzazu Rodríguez-Sanz, Ascensión Peña-Cortijo, Marta Polo, Marta Mateo Morales, Eduardo Anguita-Mandly, Eduardo Anguita-Mandly, Teresa Benítez Jiménez, Celina Benavente Cuesta, Celina Benavente Cuesta, Silvia Sánchez-Ramón, Silvia Sánchez-Ramón   +24 more
doaj   +2 more sources

Cancer as secondary immunodeficiency. Review

Revista Alergia México, 2016
The secondary immunodeficiency’s, previously presented in immunocompetent individuals. The lack of primary or secondary response to the presence of a foreign antigen, in the case of infections is a sentinel data in the diagnosis of immunodeficiency (can ...
María Eugenia Vargas-Camaño, Ricardo Leopoldo Guido-Bayardo, Nora Ernestina Martínez-Aguilar, María Isabel Castrejón-Vázquez   +3 more
doaj   +3 more sources

Clinical and laboratory characteristics of patients with symptomatic secondary immunodeficiency following the treatment of haematological malignancies [PDF]

eJHaem, 2023
Secondary immunodeficiency (SID), manifesting as increased susceptibility to infection, is an emergent clinical problem in haematoncology. Management of SID includes vaccination, prophylactic antibiotics (pAbx) and immunoglobulin replacement therapy ...
Adrian M. Shields, Sian E. Faustini, Siobhan Young, Sarah Terjesen, Nicholas I. McCarthy, Rachel L. Anderson, Mark T. Drayson, Alex G. Richter   +7 more
doaj   +2 more sources

Secondary Immunodeficiency and Non-cystic Fibrosis Bronchiectasis [PDF]

Tuberculosis and Respiratory Diseases
Bronchiectasis is a chronic respiratory disease characterized by abnormal dilation of the bronchi that causes cough, sputum, and recurrent infections. As it may be associated with various respiratory or systemic diseases, a critical aspect of managing ...
Sungmin Zo, Ji-Yong Moon, Kyung Hoon Min, Hyun Lee   +3 more
doaj   +2 more sources